Download PPT - Altogen Biosystems

Leading Developer and Manufacturer of In Vivo and DNA Transfection
Kits, Transfection Reagents and Electroporation Delivery Products
Products >
NCI-H1299 Transfection Reagent (Lung Adenocarcinoma)
Altogen Biosystems offers the NCI-H1299 Transfection Reagent
among a host of 100+ cell line specific In Vitro Transfection Kits.
NCI-H1299 Transfection Reagent is an advanced formulation of
lipid based reagent, and it has been developed to provide high
transfection efficiency with NCI-H1299 and other lung cancer cell
lines.
This cell line is a good host for studying lung cancer and related
areas of study. When cultured in vitro, NCI-H1299 cells are a
monolayer and adhere to the surface of the culture flask.
Other applications include drug discovery, gene expression
studies, molecular and cell biology research applications.
Purchase NCI-H1299 Transfection Kit at www.Altogen.com
Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA
Telephone  702 349 6103  Fax  702 989-0841  email  [email protected]
Leading Developer and Manufacturer of In Vivo and DNA Transfection
Kits, Transfection Reagents and Electroporation Delivery Products
NCI-H1299 Transfection Reagent (Lung Adenocarcinoma)
NCI-H1299 Cell Line Description and Applications
Products >
High Density NCI-H1299 Cells
atcc.org
The NCI-H1299 line originates from the lung cells
of a 43-year old Caucasian male patient suffering
from non-small cell lung cancer. The patient
received radiation prior to cell line establishment.
The cell line is specifically derived from a lymph
node metastatic site. The NCI-H1299 cell line
displays epithelial morphology and stain positive
for keratin and vimentin and produce neuromedin
B. The NCI-H1299 cell line has a partial deletion
of the p53 protein and lacks expression of the
p53 protein. This cell line is particularly useful
research related to lung cancer.
Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA
Telephone  702 349 6103  Fax  702 989-0841  email  [email protected]
Leading Developer and Manufacturer of In Vivo and DNA Transfection
Kits, Transfection Reagents and Electroporation Delivery Products
NCI-H1299 Transfection Reagent (Lung Adenocarcinoma)
NCI-H1299 Transfection Protocol
Products >
1. Plate 10,000 - 15,000 NCI-H1299 cells per well in 0.5 ml of complete growth medium 12–24 hours prior to
transfection
2. Wash with 1xPBS and add 0.5 ml of fresh growth medium
3. Prepare transfection complexes by mixing 40 µl of serum-free medium, 5.5 µl of transfection reagent, and
• 750 ng DNA (or mRNA), or
• 30 nM - 50 nM of siRNA (or microRNA)
*Referred to a final volume including growth medium
4. Incubate transfection complexes at RT for 15 - 30 minutes
5. Optional: Add 2 µl of Complex Condenser. This reagent reduces the size of transfection complex,
therefore increasing transfection efficiency; however it may increase cell toxicity
6. Add prepared transfection complexes to 0.5 ml of complete growth medium with NCI-H1299 cells (from
step 2)
7. Incubate cells at 37ºC in a humidified CO2 incubator
8. Assay for phenotype or target gene expression 48 - 72 hours after transfection
Optional: Transfection efficiency can be increased by addition of Transfection Enhancer reagent. Add 2 µl of
Transfection Enhancer reagent 12-24 hours after transfection
If the viability of NCI-H1299 cells being transfected is affected at 16 - 24 hours post-transfection, the level of
cytotoxicity can be decreased by changing the growth medium and eliminating redundant exposure of cells to
transfectant
Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA
Telephone  702 349 6103  Fax  702 989-0841  email  [email protected]
Leading Developer and Manufacturer of In Vivo and DNA Transfection
Kits, Transfection Reagents and Electroporation Delivery Products
NCI-H1299 Transfection Reagent (Lung Adenocarcinoma)
General Lipoplex-mediated Transfection Mechanism of Action
Products >
Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA
Telephone  702 349 6103  Fax  702 989-0841  email  [email protected]
Leading Developer and Manufacturer of In Vivo and DNA Transfection
Kits, Transfection Reagents and Electroporation Delivery Products
NCI-H1299 Transfection Reagent (Lung Adenocarcinoma)
NCI-H1299 Transfection Kit Product Details
Products >
•
Two component formulation enhances lipid mediated transfection efficiency
•
Optimized easy-to-use transfection protocol provided for transfection of siRNA, DNA,
mRNA, and microRNA
•
Kit includes Transfection Enhancer reagent and recommended transfection protocol
•
High transfection efficacy in the presence of serum
•
Expand your RNAi application with a reagent optimized for delivery of both siRNA and
plasmid
•
Reproducible transfection results
•
Works well for standard reverse transfection and high-throughput applications
Developed and manufactured by Altogen Biosystems (www.Altogen.com)
Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA
Telephone  702 349 6103  Fax  702 989-0841  email  [email protected]
Leading Developer and Manufacturer of In Vivo and DNA Transfection
Kits, Transfection Reagents and Electroporation Delivery Products
Products >
NCI-H1299 Transfection Reagent (Lung Adenocarcinoma)
Data
Figure 1. GAPD mRNA levels were quantified using real-time RT-PCR in the NCI-H1299 cells transfected
with siRNAs targeting GAPD or non-silencing siRNA. Forty-eight hours post-transfection, the cells were
harvested and analyzed by real-time RT-PCR for GAPD mRNA expression levels. Data were normalized
against the 18S rRNA signal. Control samples were either mock-transfected or untreated. Values are
normalized to untreated sample. Data are means ± SD (n=5).
Leading Developer and Manufacturer of In Vivo and DNA Transfection
Kits, Transfection Reagents and Electroporation Delivery Products
Products >
NCI-H1299 Transfection Reagent (Lung Adenocarcinoma)
Data
Figure 2. Protein expression of GAPDH in NCI-H1299 cells. DNA plasmid expressing GAPDH or siRNA
targeting GAPDH were transfected into NCI-H1299 cells following Altogen Biosystems transfection protocol. At
72 hours post-transfection the cells were analyzed by Western Blot for protein expression levels (normalized by
total protein, 10 µg of total protein loaded per each well). Untreated cells used as a negative control.
Leading Developer and Manufacturer of In Vivo and DNA Transfection
Kits, Transfection Reagents and Electroporation Delivery Products
NCI-H1299 Transfection Reagent (Lung Adenocarcinoma)
NCI-H1299 Transfection Kit Benefits
Products >
• Pre-optimized transfection protocol for NCI-H1299 cell line
• Compatible with DNA, small RNA (siRNA, shRNA, miRNA), mRNA, and small protein complexing
• Free of serum and protein of animal origin
• Compatible with standard and reverse transfection methods (both protocols provided in the kit manual)
• Easy to use NCI-H1299 transfection protocol ensures great performance with expedited experimental
timeline
• Equally efficient for single or multiple transfections
• Can be used for transient transfection and development of stable NCI-H1299 cell lines
• Bio-degradable after endocytosis
• Used for preclinical research worldwide
Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA
Telephone  702 349 6103  Fax  702 989-0841  email  [email protected]